

LONDON (Alliance News) - Oxford Biomedica PLC Thursday posted a widened pretax loss for 2013, as revenue wound down from its long-term collaboration w...


- Losses widen in challenging year - Clinical trials suspended for five months - Making solid progress throughout pipeline Shares in Oxford BioMedic...